OSL 7.14% 1.3¢ oncosil medical ltd

Ann: First patient treated in the UK for the TRIPP-FXX study, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,417 Posts.
    lightbulb Created with Sketch. 241
    TT

    Why was this study not done 10 years ago like you suggest? Why was there no RCT study if it’s the so called gold standard for public reimbursement? Is there any explanation provided?
 
watchlist Created with Sketch. Add OSL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.